Determinants of growth hormone receptor down-regulation
- PMID: 17488973
- DOI: 10.1210/me.2007-0138
Determinants of growth hormone receptor down-regulation
Abstract
GH receptor (GHR) is a cytokine receptor family member that responds to GH by activation of the receptor-associated tyrosine kinase, JAK2 (Janus family of tyrosine kinase 2). We previously showed that JAK2, in addition to being a signal transducer, dramatically increases the half-life of mature GHR, partly by preventing constitutive GHR down-regulation. Herein we explored GHR and JAK2 determinants for both constitutive and GH-induced GHR down-regulation, exploiting the previously characterized GHR- and JAK2-deficient gamma2A reconstitution system. We found that JAK2's ability to protect mature GHR from rapid degradation measured in the presence of the protein synthesis inhibitor, cycloheximide, depended on the presence of GHR's Box 1 element and the intact JAK2 FERM (band 4.1/Ezrin/Radixin/Moesin); domain, but not the kinase-like or kinase domains of JAK2. Thus, GHR-JAK2 association, but not JAK2 kinase activity, is required for JAK2 to inhibit constitutive GHR down-regulation and enhance GHR half-life. In cells that expressed JAK2, but not cells lacking JAK2, GH markedly enhanced GHR degradation. Like JAK2-induced protection from constitutive down-regulation, GH-induced GHR down-regulation required the GHR Box 1 element and an intact JAK2 FERM domain. However, a JAK2 mutant lacking the kinase-like and kinase domains did not mediate GH-induced GHR down-regulation. Likewise, a kinase-deficient JAK2 was insufficient for this purpose, indicating that kinase activity is required. Both lactacystin (a proteasome inhibitor) and chloroquine (a lysosome inhibitor) blocked GH-induced GHR loss. Interestingly, GH-induced GHR ubiquitination, like down-regulation, was prevented in cells expressing a kinase-deficient JAK2 protein. Further, a GHR mutant, of which all the cytoplasmic tyrosine residues were changed to phenylalanines, was resistant to GH-induced GHR ubiquitination and down-regulation. Collectively, our data suggest that determinants required for JAK2 to protect mature GHR from constitutive degradation differ from those that drive GH-induced GHR down-regulation. The latter requires GH-induced JAK2 activation and GHR tyrosine phosphorylation and is correlated to GHR ubiquitination in our reconstitution system.
Similar articles
-
Janus kinase 2 enhances the stability of the mature growth hormone receptor.Endocrinology. 2005 Nov;146(11):4755-65. doi: 10.1210/en.2005-0514. Epub 2005 Aug 4. Endocrinology. 2005. PMID: 16081639
-
Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling.Mol Endocrinol. 2003 Nov;17(11):2211-27. doi: 10.1210/me.2003-0256. Epub 2003 Aug 14. Mol Endocrinol. 2003. PMID: 12920237
-
Endoplasmic reticulum-associated degradation of growth hormone receptor in Janus kinase 2-deficient cells.Endocrinology. 2007 Dec;148(12):5955-65. doi: 10.1210/en.2007-0455. Epub 2007 Aug 30. Endocrinology. 2007. PMID: 17761766
-
Growth hormone receptor: structure and signal transduction.Eur J Endocrinol. 1995 Dec;133(6):654-9. doi: 10.1530/eje.0.1330654. Eur J Endocrinol. 1995. PMID: 8548048 Review.
-
Signalling pathway of GH.Endocr J. 1996 Oct;43 Suppl:S65-70. doi: 10.1507/endocrj.43.suppl_s65. Endocr J. 1996. PMID: 9076344 Review.
Cited by
-
Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues.Endocrinology. 2012 May;153(5):2311-22. doi: 10.1210/en.2011-1452. Epub 2012 Mar 13. Endocrinology. 2012. PMID: 22416081 Free PMC article.
-
Jak2 is a negative regulator of ubiquitin-dependent endocytosis of the growth hormone receptor.PLoS One. 2011 Feb 9;6(2):e14676. doi: 10.1371/journal.pone.0014676. PLoS One. 2011. PMID: 21347402 Free PMC article.
-
Dynamic and prognostic proteomic associations with FEV1 decline in chronic obstructive pulmonary disease.medRxiv [Preprint]. 2024 Aug 8:2024.08.07.24311507. doi: 10.1101/2024.08.07.24311507. medRxiv. 2024. PMID: 39148837 Free PMC article. Preprint.
-
Classical and novel GH receptor signaling pathways.Mol Cell Endocrinol. 2020 Dec 1;518:110999. doi: 10.1016/j.mce.2020.110999. Epub 2020 Aug 22. Mol Cell Endocrinol. 2020. PMID: 32835785 Free PMC article. Review.
-
Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).Mol Cell Endocrinol. 2019 Jul 15;492:110445. doi: 10.1016/j.mce.2019.05.004. Epub 2019 May 14. Mol Cell Endocrinol. 2019. PMID: 31100495 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous